Author: philip onyeaka

18 Jan

Low-Dose CT for Lung Screening: Who Qualifies and What to Expect

by philip onyeaka Jan 18 2026 11 Respiratory Health

Low-dose CT lung screening saves lives by catching cancer early. Learn who qualifies, what results mean, and why so few eligible people get tested-even though it's free and proven to cut deaths by 20%.

17 Jan

Medications That Are High-Risk for Seniors: What to Review

by philip onyeaka Jan 17 2026 10 Medications

Many common medications pose serious risks to seniors, including sleep aids, diabetes drugs, and antihistamines. Learn which ones to review, safer alternatives, and how to prevent dangerous side effects using the Beers Criteria.

16 Jan

How to Prioritize Replacements for Expired Critical Medications

by philip onyeaka Jan 16 2026 14 Medications

Learn how to safely prioritize replacements for expired critical medications using evidence-based protocols, tiered alternatives, and pharmacist-led systems to prevent patient harm and medication errors.

15 Jan

Pioglitazone Safety: What You Need to Know About Heart Failure, Edema, and Bladder Risks

by philip onyeaka Jan 15 2026 15 Medications

Pioglitazone lowers blood sugar but carries serious risks: heart failure, fluid retention, and possible bladder cancer. Learn who should avoid it, what symptoms to watch for, and safer alternatives available today.

14 Jan

Insurance Prior Authorization for Generic Alternatives: Navigating Policies in Pharmacy Practice

by philip onyeaka Jan 14 2026 11 Medications

Prior authorization for generic alternatives is a costly, time-consuming hurdle in pharmacy practice. Learn how insurers enforce step therapy, why denials happen, and what strategies actually work to get patients their meds faster.

10 Jan

How to Work with Your Doctor to Deprescribe and Save Money on Medications

by philip onyeaka Jan 10 2026 13 Medications

Learn how to safely stop unnecessary medications with your doctor to cut prescription costs, reduce side effects, and avoid hospital visits. Real strategies, real savings.

9 Jan

Cost Comparison: Authorized Generics vs First-to-File Generics in the U.S. Drug Market

by philip onyeaka Jan 9 2026 13 Pharmacy Savings

Authorized generics and first-to-file generics both cut drug costs, but authorized generics drive deeper price drops during the critical 180-day exclusivity window. Learn how they compare and how to save more on prescriptions.

8 Jan

How to Identify a Legitimate Generic Drug at the Pharmacy

by philip onyeaka Jan 8 2026 8 Medications

Learn how to spot a legitimate generic drug at the pharmacy by checking labels, pill appearance, and pharmacy credentials. Avoid counterfeit medications with these simple verification steps backed by FDA guidelines.

3 Jan

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

by philip onyeaka Jan 3 2026 9 Pharmaceuticals

Big pharma is using legal tricks to block cheaper generic drugs from replacing expensive brand-name medicines. Learn how product hopping, REMS abuse, and court rulings are shaping the fight over drug prices and competition.

1 Jan

Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat It in an Emergency

by philip onyeaka Jan 1 2026 15 Medications

Euglycemic DKA can strike people on SGLT2 inhibitors even with normal blood sugar. Learn the warning signs, how emergency teams treat it, and what you must do to stay safe.

31 Dec

Pomegranate Juice and Medication Interactions: What You Need to Know

by philip onyeaka Dec 31 2025 10 Medications

Pomegranate juice may affect how your body processes certain medications, especially blood thinners like warfarin. Learn which drugs are at risk, what the science really says, and how to drink it safely without compromising your treatment.

28 Dec

Bioequivalence Testing for Generic Drugs: What It Really Proves

by philip onyeaka Dec 28 2025 15 Medications

Bioequivalence testing proves generic drugs work the same as brand-name versions by measuring how quickly and completely your body absorbs the active ingredient. It's the science behind safe, affordable generics.

Author: philip onyeaka - Page 2